Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence
Crossref DOI link: https://doi.org/10.1007/s40273-025-01513-z
Published Online: 2025-07-04
Published Print: 2025-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Woods, Beth https://orcid.org/0000-0002-7669-9415
Palacios, Alfredo https://orcid.org/0000-0001-7684-0880
Sculpher, Mark https://orcid.org/0000-0003-3746-9913
Text and Data Mining valid from 2025-07-04
Version of Record valid from 2025-07-04
Article History
First Online: 4 July 2025